Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
202,731,676
-
Total 13F shares
-
12,628,676
-
Share change
-
+989,444
-
Total reported value
-
$193,544,419
-
Price per share
-
$15.56
-
Number of holders
-
41
-
Value change
-
+$15,204,345
-
Number of buys
-
29
-
Number of sells
-
12
Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q1 2020
As of 31 Mar 2020,
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,628,676 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., BVF INC/IL, BlackRock Inc., Ikarian Capital, LLC, Ghost Tree Capital, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, MANGROVE PARTNERS, MILLENNIUM MANAGEMENT LLC, and Polar Capital LLP.
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.